ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,435Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 351

$1.42M Total Retail Price of All Prescriptions

Rank: 6 out of 351

976 Patients Receiving at Least One Drug in Part D
26% Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Georgia
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 976 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

4% of this provider’s 976 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Brand Name Drugs

13% of this provider’s prescriptions were for brand-name drugs, compared to an average of 17%.

Prescription Price

$86 was the average price of a prescription from this provider, compared to $96 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Georgia
QUETIAPINE FUMARATE 1,037 290 229 A 1 2
RISPERIDONE 850 250 182 A 2 3
TRAZODONE HCL 839 193 213 3 1
ALPRAZOLAM 683 218 144 B 4 5
MIRTAZAPINE 620 205 147 5 13
DIVALPROEX SODIUM ER 615 51 166 6 17
BENZTROPINE MESYLATE 586 113 132 R 7 6
SERTRALINE HCL 553 160 126 8 7
LAMOTRIGINE 535 106 104 9 12
CITALOPRAM HBR 509 184 98 10 8
CLONAZEPAM 478 72 94 B 11 4
VENLAFAXINE HCL ER 406 157 86 12 14
GABAPENTIN 394 91 104 13 23
BUPROPION XL 386 93 86 14 19
FLUOXETINE HCL 377 45 80 15 9
OLANZAPINE 369 44 99 A 16 10
ZIPRASIDONE HCL 360 54 80 A 17 20
ZOLPIDEM TARTRATE 345 97 67 18 11
LITHIUM CARBONATE 342 73 86 19 28
BUSPIRONE HCL 330 125 104 20 25
ABILIFY 292 68 64 A 21 16
CARBAMAZEPINE 261 33 48 22 43
ESCITALOPRAM OXALATE 241 87 58 23 18
PAROXETINE HCL 211 34 34 24 22
HYDROXYZINE PAMOATE 205 45 53 R 25 26
CYMBALTA 201 75 50 26 15
DIAZEPAM 157 <11 26 B 27 30
DIVALPROEX SODIUM 152 67 51 28 29
PROPRANOLOL HCL 141 <11 32 29 49
HALOPERIDOL 140 23 38 A 30 27
AMITRIPTYLINE HCL 131 <11 25 R 31 37
LORAZEPAM 130 40 35 B 32 21
DONEPEZIL HCL 116 86 25 33 35
HYDROCODONE-ACETAMINOPHEN 114 36 18 S3 34 50
NAMENDA 109 91 21 35 33
CLOZAPINE 102 <11 15 A 36 31
BUPROPION HCL SR 93 16 24 37 24
INVEGA 88 0 17 A 38 48
PERPHENAZINE 85 <11 15 A 39 56
PRISTIQ ER 84 59 17 40 46
SUBOXONE 83 <11 15 S3 41 47
CLOMIPRAMINE HCL 81 <11 19 R 42 98
FLUVOXAMINE MALEATE 81 0 11 42 59
CHLORPROMAZINE HCL 78 31 14 A 44 69
TOPIRAMATE 78 20 17 44 32
NAPROXEN 67 <11 24 46 112
OXCARBAZEPINE 66 0 12 47 39
DOXEPIN HCL 61 19 17 48 42
INVEGA SUSTENNA 57 0 16 A 49 36
RISPERDAL CONSTA 53 <11 14 A 50 45
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.